Delforno C, Holt P J, Marks R
Br J Dermatol. 1978 Jun;98(6):619-23. doi: 10.1111/j.1365-2133.1978.tb03579.x.
Changes in the epidermis following application of three corticosteroids, betamethasone 17-valerate, hydrocortisone 17-butyrate, and hydrocortisone have been studied histometrically in human volunteers. The reduction in epidermal thickness observed correlated significantly with a reduction in size of the viable epidermal cells. There was no significant reduction in the number of cells constituting the viable epidermis. These findings indicate that thinning of the epidermis is a function of cell size rather than cell number. The epidermal changes developed quickly and were rapidly reversible. It is suggested that measurement of cell size may be an early and sensitive index of atrophogenicity induced by topical corticosteroids. 0.1% Hydrocortisone 17-butyrate and 0.1% betamethasone 17-valerate showed equivalent potency in causing epidermal thinning and reduction in cell size. Reduction in cell size paralleled increasing concentrations of betamethasone 17-valerate, indicating a positive dose-effect relationship.
在人类志愿者中,已采用组织测量法研究了三种皮质类固醇(戊酸倍他米松、丁酸氢化可的松和氢化可的松)外用后表皮的变化。观察到的表皮厚度减少与活表皮细胞大小的减小显著相关。构成活表皮的细胞数量没有显著减少。这些发现表明,表皮变薄是细胞大小的函数,而非细胞数量的函数。表皮变化发展迅速且可迅速逆转。有人提出,细胞大小的测量可能是局部皮质类固醇诱导萎缩性的早期敏感指标。0.1%丁酸氢化可的松和0.1%戊酸倍他米松在引起表皮变薄和细胞大小减小方面显示出同等效力。细胞大小的减小与戊酸倍他米松浓度的增加平行,表明存在正剂量效应关系。